From the Guidelines

Yes, men should be screened for osteoporosis.

Osteoporosis is a significant health burden in men, causing substantial morbidity, mortality, and financial expenses 1.
The prevalence of osteoporosis in men is estimated to be 7% in white men, 5% in black men, and 3% in Hispanic men, and is expected to increase nearly 50% in the next 15 years 1.
The American College of Physicians recommends screening for osteoporosis in men who are at high risk for osteoporosis and are candidates for drug therapy (Grade: strong recommendation; moderate-quality evidence) 1.
Bone densitometry, including the use of a female reference database for densitometric diagnosis in men, is a recommended diagnostic approach for osteoporosis in men 1.
Cost-effectiveness of universal screening for osteoporosis in men is a concern, and may only be cost-effective in men aged 80 years or older 1.

Risk factors for osteoporosis in men, such as low bone mass, family history, and certain medical conditions, should be taken into account when selecting patients for screening 1.
Non-DXA screening tests have not been shown to be reliable for diagnosing osteoporosis in men, and DXA testing is currently the gold standard for diagnosis 1.

From the Research

Osteoporosis is a common and costly disease that is associated with high morbidity and mortality in both men and women 2
Men have osteoporotic fractures about 10 years later in life than women, and due to increasing life expectancy, more fractures are predicted 3
Important risk factors for men include advancing age, smoking or chronic obstructive pulmonary disease, glucocorticoid therapy, and androgen deprivation therapy for prostate cancer 3

Some organizations recommend screening for osteoporosis in men older than age 70 2, 3
The American College of Preventive Medicine (ACPM) recommends screening with BMD testing for osteoporosis in men aged ≥70 years, and in men aged 50-69 years with at least one major or two minor risk factors for osteoporosis 2
The Department of Veterans Affairs recommends case finding rather than screening 3

Osteoporosis in high-risk men is under-screened, with a baseline screening rate of 11% in one study 4
Creating awareness about the importance of osteoporosis screening among health care professionals can lead to improved screening rates 4
Barriers to screening include lack of awareness and inefficient targeting of high-risk men 5

There is indirect evidence to support screening for osteoporosis given the availability of medications with good antifracture efficacy 2
However, there is a lack of direct evidence supporting the benefits of bone mineral density (BMD) screening on osteoporosis outcomes 6, 2
A new study aims to determine whether a new model of primary osteoporosis screening reduces fracture risk compared to usual care 5